Evidence map›Paper›PMID 38512593›Full record

Trial reportPsychopharmacology2024

Efficacy of probiotic supplements in improving the symptoms of psychosis, anxiety, insomnia, and anorexia due to amphetamine and methamphetamine use: a randomized clinical trial.

Rahim Badrfam, Atefeh Zandifar, Amirhossein Hajialigol, Maryam Rashidian, Norman Brad Schmidt, Danielle Morabito, Mostafa Qorbani, Ehsan Shahrestanaki, Mahboobeh Mehrabani Natanzi

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Psychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Increased relative abundance ofFrontiers in sleep · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Rahim BadrfamDepartment of Psychiatry, Imam Hossein Hospital, School of Medicine, Alborz University of Medical Sciences, Karaj, Alborz, Iran.ORCID https://orcid.org/0000-0001-9808-1678
Atefeh ZandifarDepartment of Psychiatry, Imam Hossein Hospital, School of Medicine, Alborz University of Medical Sciences, Karaj, Alborz, Iran. zandifaratefe@gmail.com.ORCID http://orcid.org/0000-0002-4725-1734
Amirhossein HajialigolAlborz Office of Universal Scientific Education and Research Network (USERN), Alborz University of Medical Sciences, Karaj, Iran.
Maryam RashidianAlborz Office of Universal Scientific Education and Research Network (USERN), Alborz University of Medical Sciences, Karaj, Iran.
Norman Brad SchmidtDepartment of Psychology, Florida State University, Tallahassee, Florida, USA.ORCID https://orcid.org/0000-0003-4125-9601
Danielle MorabitoDepartment of Psychology, Florida State University, Tallahassee, Florida, USA.ORCID https://orcid.org/0000-0001-8363-3249
Mostafa QorbaniNon-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.ORCID https://orcid.org/0000-0001-9465-7588
Ehsan ShahrestanakiNon-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Mahboobeh Mehrabani NatanziEvidence-Based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran.ORCID https://orcid.org/0000-0001-8879-5984
Jahrom University of Medical Sciences · IRFlorida State University · USUniversal Scientific Education and Research Network · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleChanges in the density and diversity of gut microbiota in chronic use of methamphetamine have been mentioned as contributors to psychotic and anxiety symptoms, sleep problems, and loss of appetite.

objectiveIn this placebo-controlled clinical trial, we investigated the effect of the probiotic Lactobacillus Acidophilus in improving psychiatric symptoms among hospitalized patients with chronic methamphetamine use along with psychotic symptoms.

methods60 inpatients with a history of more than 3 years of methamphetamine use, were randomly assigned to one of two groups receiving either a probiotic capsule or placebo along with risperidone for 8 weeks based on a simple randomization method. In weeks 0, 4, and 8, patients were evaluated using the Brief Psychiatric Rating Scale (BPRS), Beck Anxiety Inventory (BAI), Pittsburgh Sleep Quality Index (PSQI), Simple Appetite Nutritional Questionnaire (SANQ), and Body Mass Index (BMI).

resultsCompared to the control group, patients receiving probiotics had better sleep quality, greater appetite, and higher body mass index (there were significant interaction effects of group and time at Week 8 in these variables (t = -3.32, B = -1.83, p = .001, d = 0.89), (t = 10.50, B = 2.65, p <.001, d = 1.25) and (t = 3.40, B = 0.76, p <.001, d = 0.30), respectively. In terms of the improvement of psychotic and anxiety symptoms, there was no statistically significant difference between the two groups.

conclusionsThe use of probiotics was associated with improved sleep quality, increased appetite, and increased body mass index in patients with chronic methamphetamine use. Conducting more definitive clinical trials with larger sample sizes and longer-term follow-up of cases is recommended.

Indexed as

Amphetamine-Related DisordersAnorexiaAnxietyMethamphetamineProbioticsSleep Initiation and Maintenance DisordersAdultAmphetamineAntipsychotic AgentsDouble-Blind MethodFemaleHumansMaleMiddle AgedPsychoses, Substance-InducedPsychotic DisordersAmphetamineAntipsychotic AgentsMethamphetamineRisperidoneAnorexiaAnxietyInsomniaMethamphetamineProbioticPsychosis

Identifiers

PMID38512593
OpenAlexW4393037502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.